IM Cannabis 관리

관리 기준 확인 2/4

IM Cannabis CEO는 Oren Shuster, Oct2019 에 임명되었습니다 의 임기는 5.08 년입니다. 총 연간 보상은 CA$ 808.07K, 58.9% 로 구성됩니다. 58.9% 급여 및 41.1% 보너스(회사 주식 및 옵션 포함). 는 CA$ 2.31M 가치에 해당하는 회사 주식의 20.73% 직접 소유합니다. 2.31M. 경영진과 이사회의 평균 재임 기간은 각각 3.2 년과 2.2 년입니다.

주요 정보

Oren Shuster

최고 경영자

CA$808.1k

총 보상

CEO 급여 비율	58.9%
CEO 임기	5.1yrs
CEO 소유권	20.7%
경영진 평균 재임 기간	3.2yrs
이사회 평균 재임 기간	2.2yrs

최근 관리 업데이트

Recent updates

Slammed 28% IM Cannabis Corp. (CSE:IMCC) Screens Well Here But There Might Be A Catch

Sep 13

Don't Ignore The Fact That This Insider Just Sold Some Shares In IM Cannabis Corp. (CSE:IMCC)

Feb 05

What Percentage Of IM Cannabis Corp. (CSE:IMCC) Shares Do Insiders Own?

Jan 08

CEO 보상 분석

Oren Shuster 의 보수는 IM Cannabis 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Sep 30 2024	n/a	n/a	-CA$13m
Jun 30 2024	n/a	n/a	-CA$14m
Mar 31 2024	n/a	n/a	-CA$15m
Dec 31 2023	CA$808k	CA$476k	-CA$9m
Sep 30 2023	n/a	n/a	-CA$15m
Jun 30 2023	n/a	n/a	-CA$17m
Mar 31 2023	n/a	n/a	-CA$17m
Dec 31 2022	CA$2m	CA$506k	-CA$23m
Sep 30 2022	n/a	n/a	-CA$22m
Jun 30 2022	n/a	n/a	-CA$16m
Mar 31 2022	n/a	n/a	-CA$10m
Dec 31 2021	CA$2m	CA$516k	CA$91k
Sep 30 2021	n/a	n/a	-CA$10m
Jun 30 2021	n/a	n/a	-CA$12m
Mar 31 2021	n/a	n/a	-CA$24m
Dec 31 2020	CA$742k	CA$424k	-CA$29m
Sep 30 2020	n/a	n/a	-CA$7m
Jun 30 2020	n/a	n/a	-CA$10m
Mar 31 2020	n/a	n/a	-CA$982k
Dec 31 2019	CA$2m	CA$357k	-CA$7m

보상 대 시장: Oren 의 총 보상 ($USD 577.98K )은 Canadian 시장( $USD 169.25K ).

보상과 수익: Oren 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Oren Shuster

5.1yrs

테뉴어

CA$808,068

보상

Mr. Oren Shuster serves as the Co-owner of IMC Ltd. Mr. Shuster serves as Chief Executive Officer and Director of IM Cannabis Corp. since October 11, 2019. Mr. Shuster is a leading figure in the medical ca...

리더십 팀

이름	위치	테뉴어	보상	소유권
Oren Shuster	CEO & Director	5.1yrs	CA$808.07k	20.73% CA$ 2.3m
Uri Birenberg	Chief Financial Officer	1.1yrs	CA$325.72k	데이터 없음
Richard Balla	Chief Executive Officer of Adjupharm	4.8yrs	CA$293.97k	0.029% CA$ 3.3k
Anna Taranko	Director Investor & Public Relations	no data	데이터 없음	데이터 없음
Michal Nissimov	General Counsel	1.6yrs	데이터 없음	데이터 없음

3.2yrs

평균 재임 기간

경험이 풍부한 관리: IMCC 의 관리팀은 경험 ( 3.2 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Oren Shuster	CEO & Director	5.1yrs	CA$808.07k	20.73% CA$ 2.3m
Shmulik Arbel	Director	less than a year	데이터 없음	1.84% CA$ 205.2k
Mordechai Marcus	Independent Director	2.2yrs	CA$96.66k	데이터 없음
Brian Schinderle	Independent Director	3.8yrs	CA$135.32k	데이터 없음
Einat Zakariya	Independent Director	2.2yrs	CA$93.16k	2.06% CA$ 228.9k

2.2yrs

평균 재임 기간

경험이 풍부한 이사회: IMCC 의 이사회는 경험(평균 재직 기간 2.2 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

IM Cannabis 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

IM Cannabis Corp. Appoints Shmulik Arbel to Board of Directors

IM Cannabis Corp. Announces Executive Changes

IM Cannabis Corp., Annual General Meeting, Dec 06, 2023

IM Cannabis Corp. Announces Departure of Itay Vago as CFO

High number of new directors

High number of new directors

Recent updates

Third quarter 2024 earnings released: CA$0.41 loss per share (vs CA$0.96 loss in 3Q 2023)

New major risk - Revenue and earnings growth

IM Cannabis Corp. to Report Q3, 2024 Results on Nov 14, 2024

IM Cannabis Corp. announced that it expects to receive $1.613 million in funding

Slammed 28% IM Cannabis Corp. (CSE:IMCC) Screens Well Here But There Might Be A Catch

IM Cannabis Corp. Appoints Shmulik Arbel to Board of Directors

Price target decreased by 72% to CA$20.70

A Piece Of The Puzzle Missing From IM Cannabis Corp.'s (CSE:IMCC) Share Price

IM Cannabis Corp. announced that it has received CAD 2.091977 million in funding

First quarter 2024 earnings released: CA$0.42 loss per share (vs CA$0.027 profit in 1Q 2023)

IM Cannabis Corp. to Report Q1, 2024 Results on May 08, 2024

Full year 2023 earnings released: CA$0.74 loss per share (vs CA$3.14 loss in FY 2022)

New major risk - Revenue and earnings growth

IM Cannabis Corp. to Report Fiscal Year 2023 Results on Mar 28, 2024

Kadimastem Ltd (TASE:KDST) entered into a non-binding term sheet to acquire IM Cannabis Corp. (CNSX:IMCC) in reverse merger transaction.

IM Cannabis Announces Receipt of Court Action

Third quarter 2023 earnings released: CA$0.16 loss per share (vs CA$0.59 loss in 3Q 2022)

New major risk - Revenue and earnings growth

IM Cannabis Corp. to Report Q3, 2023 Results on Nov 13, 2023

IM Cannabis Corp. Announces Executive Changes

IM Cannabis Corp., Annual General Meeting, Dec 06, 2023

IM Cannabis Corp. Announces Departure of Itay Vago as CFO

New major risk - Market cap size

Second quarter 2023 earnings released: CA$0.26 loss per share (vs CA$0.49 loss in 2Q 2022)

IM Cannabis Corp. to Report Q2, 2023 Results on Aug 14, 2023

Potential Upside For IM Cannabis Corp. (CSE:IMCC) Not Without Risk

New major risk - Financial position

IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement

New major risk - Share price stability

IM Cannabis Corp. to Report Q1, 2023 Results on May 15, 2023

Full year 2022 earnings released: CA$3.13 loss per share (vs CA$3.07 loss in FY 2021)

Price target decreased by 72% to CA$3.45

IM Cannabis Corp. Commences Exit of Canadian Cannabis Market to Focus its Resources on Pursuing Growth Opportunities in Israel, Germany and Europe

IM Cannabis Corp. to Report Q3, 2022 Results on Nov 14, 2022

High number of new directors

High number of new directors

CEO & Director recently bought CA$157k worth of stock

Executive Chairman recently bought CA$105k worth of stock

IM Cannabis Corp. Announces Board Changes

IM Cannabis Corp. announced that it expects to receive $5 million in funding

Second quarter 2022 earnings released: CA$0.27 loss per share (vs CA$0.10 loss in 2Q 2021)

IM Cannabis Corp., Annual General Meeting, Oct 20, 2022

IM Cannabis Corp. to Report Q2, 2022 Results on Aug 15, 2022

IM Cannabis Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

First quarter 2022 earnings released: CA$0.14 loss per share (vs CA$0.11 profit in 1Q 2021)

IM Cannabis Corp. Provides Preliminary Unaudited Revenue Guidance for the Second Quarter 2022

IM Cannabis Corp. to Report Q1, 2022 Results on May 12, 2022

Price target decreased to CA$6.00

High number of new and inexperienced directors

CEO & Director recently bought CA$423k worth of stock

Full year 2021 earnings released: CA$0.31 loss per share (vs CA$0.74 loss in FY 2020)

Health Check: How Prudently Does IM Cannabis (CSE:IMCC) Use Debt?

IM Cannabis Corp. Provides Earnings Guidance for Fourth Quarter of 2021 and Full Year 2022

Price target decreased to CA$7.63

Third quarter 2021 earnings released: CA$0.06 loss per share (vs CA$0.017 profit in 3Q 2020)

Director Marc Lustig has joined 5th company board

Director Marc Lustig has joined 5th company board

Director Marc Lustig has joined 5th company board

Insider recently sold CA$76k worth of stock

Second quarter 2021 earnings released: CA$0.10 loss per share (vs CA$0.25 loss in 2Q 2020)

Price target decreased to CA$9.50

IM Cannabis Corp. Unveils Proprietary Data from A Clinical Survey Evaluating Medicinal Cannabis Therapy

First quarter 2021 earnings released: EPS CA$0.11 (vs CA$0.011 loss in 1Q 2020)

IM Cannabis Corp. Provides Earnings Guidance for the Second Quarter of 2021

Full year 2020 earnings released: CA$0.74 loss per share (vs CA$0.23 loss in FY 2019)

IM Cannabis Corp. Provides Preliminary Earnings Guidance for the First Quarter and Second Quarter of 2021

IM Cannabis Corp. (CNSX:IMCC) completed the acquisition of Trichome Financial Corp. (CNSX:TFC) from Cresco Labs Inc., Opaskawayak Cree Nation and others.

IM Cannabis Corp. Announces Board Changes

IM Cannabis Corp. to Bring Canadian Premium Indoor High-THC Medical Cannabis to Israel with Imports from GTEC Holdings Ltd